NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
4.730
+0.110 (2.38%)
At close: Dec 20, 2024, 4:00 PM
4.896
+0.166 (3.50%)
After-hours: Dec 20, 2024, 7:18 PM EST
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $35.56 million as of December 20, 2024. Its market cap has increased by 206.44% in one year.
Market Cap
35.56M
Enterprise Value
37.76M
1-Year Change
206.44%
Ranking
Category
Stock Price
$4.73
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has increased from $19.59M to $35.56M, an increase of 81.53%. That is a compound annual growth rate of 22.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 35.56M | 191.99% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VYNE Therapeutics | 36.51M |
| OneMedNet | 36.24M |
| OKYO Pharma | 36.20M |
| SAB Biotherapeutics | 35.99M |
| Actinium Pharmaceuticals | 35.56M |
| Lantern Pharma | 35.16M |
| Movano | 34.69M |
| Nexalin Technology | 34.66M |